| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.004 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |